✦ LIBER ✦

ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation

✍ Scribed by A. Uslu; Y. Tokat; E. Ok; A. Unsal; O. Ilkgul; H. Kaplan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ALG versus OKT3 for treatment of steroid

✍ D.L Stippel; W Arns; M Pollok; K.T.E Beckurts; U.J Hesse; A.H Hölscher 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Predicting Factors for Long-Term Results

✍ L. Rostaing; M.-H. Chabannier; A. Modesto; A. Rouzaud; J.-M. Cisterne; J. Tkaczu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Effectiveness of short-term OKT3 therapy

✍ M.F.C. Carvalho; T. Adoni; F.P. Saggioro; V. Soares 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Long-term results after primary successf

✍ V. Kliem; D. Schaumann; G. Ehlerding; O.K. Eberhard; V. Lufft; H.J. Schlitt; R. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Low-dose OKT3 is not effective in the tr

✍ W.C Lye; A Vathsala; W.T Lee; S.O Leong 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Evaluation of OKT3 monoclonal antibody a

✍ Manuel Mochon; Bruce Kaiser; Jo Ann Palmer; Martin Polinsky; Joseph T. Flynn; G. 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 531 KB